Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airway smooth muscle contraction in asthma

Airway remodelling describes the histopathological changes leading to fixed airway obstruction in patients with asthma and includes extra-cellular matrix (ECM) deposition. Matrix metalloproteinase-1 (MMP-1) is present in remodelled airways but its relationship with ECM proteins and the resulting fun...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 9; no. 2; p. e90565
Main Authors Rogers, Natasha K, Clements, Debbie, Dongre, Arundhati, Harrison, Tim W, Shaw, Dominic, Johnson, Simon R
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 28.02.2014
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Airway remodelling describes the histopathological changes leading to fixed airway obstruction in patients with asthma and includes extra-cellular matrix (ECM) deposition. Matrix metalloproteinase-1 (MMP-1) is present in remodelled airways but its relationship with ECM proteins and the resulting functional consequences are unknown. We used airway smooth muscle cells (ASM) and bronchial biopsies from control donors and patients with asthma to examine the regulation of MMP-1 by ECM in ASM cells and the effect of MMP-1 on ASM contraction. Collagen-I and tenascin-C induced MMP-1 protein expression, which for tenascin-C, was greater in asthma derived ASM cells. Tenascin-C induced MMP-1 expression was dependent on ERK1/2, JNK and p38 MAPK activation and attenuated by function blocking antibodies against the β1 and β3 integrin subunits. Tenascin-C and MMP-1 were not expressed in normal airways but co-localised in the ASM bundles and reticular basement membrane of patients with asthma. Further, ECM from asthma derived ASM cells stimulated MMP-1 expression to a greater degree than ECM from normal ASM. Bradykinin induced contraction of ASM cells seeded in 3D collagen gels was reduced by the MMP inhibitor ilomastat and by siRNA knockdown of MMP-1. In summary, the induction of MMP-1 in ASM cells by tenascin-C occurs in part via integrin mediated MAPK signalling. MMP-1 and tenascin-C are co-localised in the smooth muscle bundles of patients with asthma where this interaction may contribute to enhanced airway contraction. Our findings suggest that ECM changes in airway remodelling via MMP-1 could contribute to an environment promoting greater airway narrowing in response to broncho-constrictor stimuli and worsening asthma symptoms.
Bibliography:Competing Interests: Professor Johnson holds grants from the MRC, BBSRC and LAM Action. He has received fees for speaking from Novartis. Dr. Harrison has received grants from the NIHR and funding for conference travel and advisory boards from Boehringer Ingleheim, Napp, and AstraZeneca. Dr. Shaw has received grants from the NIHR, Asthma UK, and the BMA. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: SRJ DC NR. Performed the experiments: NR DC AD. Analyzed the data: SRJ NR AD. Contributed reagents/materials/analysis tools: SRJ TWH DS. Wrote the paper: SRJ NR AD TWH DS.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0090565